Presented by In collaboration with

2022 Healthcare Summit

MORNING SESSION

Session Topics Speakers

09:00 – 09:25 REGISTRATION

09:25 – 09:30 Welcome address Annie Lee (Managing Director, CBC Group)

09:30 – 10:10 US-China: collision, co-existence, or co-operation? Implications for Kishore Mahbubani (Distinguished Fellow, NUS)
global investors

10:10 – 10:30 Unmet medical needs in emerging markets Vikram Kapur (Senior Partner, Bain & Company)

TEA BREAK (20 MINS)

10:50 – 11:20 Improving accessibility in emerging markets and CBC’s vision Fu Wei (CEO, CBC Group)

11:20 – 12:00 Future pandemic readiness Sean Fu (Moderator; CEO, RVAC)

Andre Choo (Exec. Director, A*STAR)
Mathai Mammen (EVP Pharma R&D, J&J)
Lisa Ng (Exec. Director, A*STAR)
Gladys Tan (Director, DSO National Lab)

12:00 – 12:30 How to build a multi-billion company via M&A Michael Keyoung (Moderator; MD, CBC Group)
Brent Saunders (Chairman, Hugel)

LUNCH & NETWORKING SESSION (75 MINS)

AFTERNOON SESSION

13:45-14:15 Public-private partnership driving healthcare innovation to impact Prof. Tan Sze Wee (Assistant CE, Innovation &
Enterprise, A*STAR)

14:15-14:45 Enhancing healthcare access and affordability through technology Steve Oesterle (Senior Advisor, CBC Group)

14:45-15:25 Medtech in the APAC region: Opportunities and challenges Steve Oesterle (Moderator; Sr Advisor, CBC)
Leslie Hsu (VP, CFO APAC, Medtronic)
Stephen Morse (SVP & Pres. APAC, Boston Sci)
Huimin Wang (Corp. VP, Edwards)
Ashley Wittorf (Head of BD APAC, J&J)

TEA BREAK (20 MINS)

15:45-16:05 Current state of the biopharma industry Roger Perlmutter (CEO, Eikon Tx)

16:05-16:45 Emerging biopharma innovation trends John Tsai (Moderator; Former President, Global Drug
Development & CMO, Novartis)
Shengfang Jin (CSO, Ensem Tx)
Kerry Blanchard (Advisor, Everest Medicines)
Zhenhai Gao (President & CEO, NiKang Tx)
Eiichi Takahashi (CEO, Jadeite Med)
Mohamed E.H. Elsayed (CTO, RVAC)

16:45-16:55 Closing remarks Annie Lee (Managing Director, CBC Group)